Novel method for going back to memories shows promise in treatment of depression

NewsGuard 100/100 Score

A randomized controlled trial that has appeared in the current issue of Psychotherapy and Psychosomatics indicates that a new method for going back to memories may be of help in depression.

Increasingly, research indicates that therapies that target the recall of autobiographical memories as the core foci of interest have promise in the treatment of depression. The integration of reminiscence and cognitive psychotherapies has led to the development of cognitive-reminiscence therapy (CRT), an effective treatment for depression in older adults. Although reminiscence therapies have been empirically validated almost exclusively in older adult populations, Authors tested if they could be equally beneficial for depressed younger adults. In this pilot study, 26 young adults were recruited from a community youth mental health service for 12- to 25-year-olds and randomized to receive CRT or usual care.

Results show that individually administered CRT had large effects on depressive symptoms, which were manifest immediately following the final session, and maintained after 3 months. On secondary outcomes, large effects were found and maintained at follow-up. These findings provide evidence that guided reviewing of autobiographical memory with young adults has effects on a range of psychological resources: self-worth, confidence in the capacity to achieve goals and cope with challenges, the perception of meaning in one's life, and a positive future orientation. These findings are novel in providing preliminary evidence that this intervention approach is feasible and effective for young adults.

Source:

Journal of Psychotherapy and Psychosomatics

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Low dose esketamine injection after childbirth reduces postpartum depression